1. Home
  2. MTX vs HAE Comparison

MTX vs HAE Comparison

Compare MTX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Minerals Technologies Inc.

MTX

Minerals Technologies Inc.

HOLD

Current Price

$73.12

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$57.27

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTX
HAE
Founded
1968
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
MTX
HAE
Price
$73.12
$57.27
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$81.33
$85.38
AVG Volume (30 Days)
171.5K
587.3K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
44.54
EPS
N/A
2.46
Revenue
$2,072,600,000.00
$910,373,000.00
Revenue This Year
$5.66
N/A
Revenue Next Year
$4.47
$5.23
P/E Ratio
N/A
$23.79
Revenue Growth
N/A
N/A
52 Week Low
$49.54
$47.32
52 Week High
$75.30
$87.32

Technical Indicators

Market Signals
Indicator
MTX
HAE
Relative Strength Index (RSI) 60.70 42.16
Support Level $64.99 $55.95
Resistance Level $75.30 $66.86
Average True Range (ATR) 1.83 1.81
MACD 0.43 0.44
Stochastic Oscillator 90.35 44.58

Price Performance

Historical Comparison
MTX
HAE

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: